Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 83.68

+0.1%

Nov 28 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1837)	10/8/2007 2:52:57 PM
From: Jibacoa	Read Replies (1) of 3722

MATK traded at a 52 wks H today. bigcharts.marketwatch.com It announced a new 10 Yrs. agreements with ABT. MATK will be ABT's exclusive worldwide DHA and ARA supplier for all of its infant formula products.(MATK had a previous 25 Yrs. agreement to supply DHA & ARA to ABT, which remains in effect, but in the new contract ABT has committed to purchase all of its worldwide DHA and ARA requirements from MATK.<g> Will see how long it will thake the stock to get back to the $40 level.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next